Enhanced Brain Clearance of Tau and Amyloid-β in Alzheimer’s Disease Patients by Transcranial Radiofrequency Wave Treatment: A Central Role of Vascular Endothelial Growth Factor (VEGF)
Open Access
- 20 August 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 100 (s1) , S223-S241
Abstract
Background: While drainage/removal of fluid and toxins from the brain by cerebrospinal fluid (CSF) directly into venous blood is well-known, a second drainage route has recently been (re)discovered—meningeal lymphatic vessels (mLVs)—which are responsible for up to half of total brain fluid/toxin drainage. The cytokine vascular endothelial growth factor (VEGF) increases mLV diameter and numbers to increase mLV drainage, resulting in increased mLV drainage. Alzheimer’s disease (AD) is characterized by low plasma and CSF levels of VEGF. Objective: To determine if non-invasive transcranial radiofrequency wave treatment (TRFT), through modulation of VEGF levels in blood and CSF, can affect removal of toxins tau and amyloid-β (Aβ) from the brain. Methods: Eight mild/moderate AD subjects were given twice-daily 1-hour TRFT sessions at home by their caregivers. Blood and CSF samples were taken at baseline and following completion of 2 months of TRFT. Results: In plasma and/or CSF, strong baseline correlations between VEGF levels and AD markers (t-tau, p-tau, Aβ1-40, Aβ1-42) were eliminated by TRFT. This effect was primarily due to TRFT-induced increases in VEGF levels in AD subjects with low or unmeasurable “baseline” VEGF levels. These increased VEGF levels were associated with increased clearance/drainage of tau and Aβ from the brain, likely through VEGF’s actions on mLVs. Conclusions: A new mechanism of TRFT is identified (facilitation of brain tau and Aβ clearance via VEGF) that is likely contributory to TRFT’s reversal of cognitive impairment in AD subjects. TRFT may be particularly effective for cognitive benefit in AD subjects who have low VEGF levels.Keywords
This publication has 55 references indexed in Scilit:
- Drainage of senescent astrocytes from brain via meningeal lymphatic routesBrain, Behavior, and Immunity, 2022
- Continuous theta burst stimulation dilates meningeal lymphatic vessels by up-regulating VEGF-C in meningesNeuroscience Letters, 2020
- Plasma biomarkers of astrocytic and neuronal dysfunction in early‐ and late‐onset Alzheimer's diseaseAlzheimer's & Dementia, 2020
- Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast CancerPathology and Oncology Research, 2018
- The Meningeal Lymphatic System: A New Player in NeurophysiologyNeuron, 2018
- Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s DiseaseCell Reports, 2018
- Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer’s Disease?Neuron, 2016
- The Role of Vascular Endothelial Growth Factor in Neurodegeneration and Cognitive DeclineJAMA Neurology, 2015
- Impairment of paravascular clearance pathways in the aging brainAnnals of Neurology, 2014
- Human Choroid Plexus Growth Factors: What Are the Implications for CSF Dynamics in Alzheimer's Disease?Experimental Neurology, 2001